> We saw silver drop 40% which hasn't happened since 1980
40% pullback but still up 150% over the past year..
It was the same on Silver Thursday in 1980 too. And then it went sideways for a couple decades.
Readit Newskhuey commented on Videogame stocks slide after Google's Project Genie AI model release reuters.com/business/vide... · Posted by u/speckx
Just which prominent publishers remain private, anyway? Besides Valve.
Epic.
The typical demonym is inaccurate.
It is more or less “USian” in some other languages, and no one raises an eyebrow. 美国人, 米国人, etc.
> It is more or less “USian” in some other languages, and no one raises an eyebrow. 美国人, 米国人, etc.
Given that both of those examples come from phonetics for America I don't think that proves what you think it does. It's not 合众国人 ...
khuey commented on Amazon closing its Fresh and Go stores finance.yahoo.com/news/am... · Posted by u/trenning
Reminds me of the time they made towns all around the US do a dog and pony show to attract "HQ2" and then just located it where Bezos wanted to be all along. I remember AOC getting it right all along, she did the most milktoast of pushback in her district and it caused Amazon to huff and puff and just walk away(causing many property speculators to lose out). She got raked over the coals but a few years later and the place HQ2 ended up didn't fare so well. AOC was vindicated.
My hope is that more towns learn from your experience and don't tolerate this nonsense anymore.
> milktoast
fyi since you may not have ever seen it spelled before it's milquetoast
khuey commented on GPTZero finds 100 new hallucinations in NeurIPS 2025 accepted papers gptzero.me/news/neurips/... · Posted by u/segmenta
It's not always possible to distinguish between fake citations and citations that are simply hard to find (e.g. wonderful old books that aren't on the Internet).
Another problem is that conferences move slowly and it's hard to adjust the publication workflow in such an invasive way. CVPR only recently moved from Microsoft's CMT to OpenReview to accept author submissions, for example.
There's a lot of opportunity for innovation in this space, but it's hard when everyone involved would need to agree to switch to a different workflow.
(Not shooting you down. It's just complicated because the people who would benefit are far away from the people who would need to do the work to support it...)
Sure, I agree that it's far from trivial to implement.
khuey commented on GPTZero finds 100 new hallucinations in NeurIPS 2025 accepted papers gptzero.me/news/neurips/... · Posted by u/segmenta
Academic venues don't have enough reviewers. This problem isn't new, and as publication volumes increase, it's getting sharply worse.
Consider the unit economics. Suppose NeurIPS gets 20,000 papers in one year. Suppose each author should expect three good reviews, so area chairs assign five reviewers per paper. In total, 100,000 reviews need to be written. It's a lot of work, even before factoring emergency reviewers in.
NeurIPS is one venue alongside CVPR, [IE]CCV, COLM, ICML, EMNLP, and so on. Not all of these conferences are as large as NeurIPS, but the field is smaller than you'd expect. I'd guess there are 300k-1m people in the world who are qualified to review AI papers.
Seems like using tooling like this to identify papers with fake citations and auto-rejecting them before they ever get in front of a reviewer would kill two birds with one stone.
khuey commented on Amazon is ending all inventory commingling as of March 31, 2026 twitter.com/ghhughes/stat... · Posted by u/MrBuddyCasino
You go to the grocery store, and if it’s not Costco, your produce is co-mingled. Is that crazy?
If my grocery store held themselves out as a banana marketplace, carried boxes from a variety of different banana companies and told me to do my own research on which ones are good, sold me a box labeled Chiquita bananas that I couldn't open until I got home, and then after I purchased it, got home, and opened it, it was full of bananas from Shitty Rotten Banana Farms LLC with fake Chiquita stickers on them, that would be pretty crazy yeah.
There is an abbreviated application for new drug approval (ANDA) pathway meant for generics, but it does not seem like H&H has gone this route. It does require you to open your supply chain up to inspections and to provide evidence that your generic version basically works the same as the brand name.
In my opinion there two things going on here that I strongly feel are true.
1. Something is systemically wrong in the US when we are cutting off people’s access to meds, like GLP-1s, which have profound health benefits.
2. Hims and Hers are also in the wrong. The rules and laws are there for a good reason. It is not just for us to arbitrarily pick and choose when to enforce them.
Are we cutting off people's access to meds or do they just not want to pay what they cost?